bpc 157 clinical trials humans musculoskeletal BPC-157 and the Difference Between an Evidence Gap and a Cover-Up: What the entire human evidence base actually looks like, and the questions to ask next. — WellFounded Heal or Harm: Body Protective
Description
Lohmander, L

Some practitioners advocate weight-based dosing (e.g., 2.5-5 g/kg daily), while others use fixed doses (250-500 g daily) regardless of body size
The gastro-resistant properties of the sucrosome shields the vitamin from premature release, degradation and minimizing interactions with food (27), as it passes through the stomach, ensuring that the B12 reaches the intestinal mucosa intact

PMID: 7 EnglishEPSwinglerRNPatwaSTosunMHowardJFMiljkoviMDet al

Controlled release of basic fibroblast growth factor from gelatin hydrogel sheet improves structural and physiological properties of vein graft in rat
